The dynamic range of circulating tumor DNA in metastatic breast cancer

Conclusions: The dynamic range of ctDNA varies substantially in patients with metastatic breast cancer. This has important implications for the use of ctDNA as a predictive and prognostic biomarker.

http://breast-cancer-research.com/content/16/4/421

Source: Breast Cancer Research - August 9, 2014 Category: Cancer & Oncology Authors: Maryam HeidaryMartina AuerPeter UlzEllen HeitzerEdgar PetruChristin GaschSabine RiethdorfOliver MauermannIngrid LaferGunda PristauzSigurd LaxKlaus PantelJochen GeiglMichael Speicher Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | Genetics | Study